Boothbay Fund Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Boothbay Fund Management’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-348,000	Closed	-$3.27M	–	1590
2020 Q3	$3.27M	Hold	348,000	–	–	0.2%	113
2020 Q2	$2.66M	Hold	348,000	–	–	0.18%	146
2020 Q1	$2.15M	Buy	348,000 +108,000	+45%	+$952K	0.18%	149
2019 Q4	$2.92M	Hold	240,000	–	–	0.25%	96
2019 Q3	$2.77M	Buy	240,000 +39,032	+19%	+$411K	0.25%	95
2019 Q2	$2.01M	Buy	200,968 +100,598	+100%	+$1.09M	0.18%	137
2019 Q1	$1.29M	Buy	+100,370	New	+$1.49M	0.13%	181
2016 Q1	–	Sell	-7,205	Closed	-$218K	–	611
2015 Q4	$218K	Sell	7,205 -2,595	-26%	-$83.8K	0.1%	376
2015 Q3	$389K	Buy	+9,800	New	+$608K	0.18%	116

Boothbay Fund Management's AMAG Position: Q4 2020 in Review

Boothbay Fund Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 348,000 shares — an estimated $3.27M sold.

Boothbay Fund Management first reported a position in AMAG in Q3 2015 and held it in 9 quarters. The position peaked at $3.27M in Q3 2020. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

Boothbay Fund Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Boothbay Fund Management sold 348,000 AMAG Pharmaceuticals shares in Q4 2020, an estimated $3.27M.
Boothbay Fund Management first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 9 quarters.
Boothbay Fund Management's AMAG Pharmaceuticals position peaked at $3.27M in Q3 2020.
1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Boothbay Fund Management's 13F filing for Q4 2020, filed 12 Feb 2021.